Olympics’ Wildcard Event, Enhanced Games, Falls Short of Hype

A Night of Performance and Controversy at Resorts World

The competition, held in a custom-built arena at Resorts World Las Vegas, brought together a diverse field of athletes, including sprinters, swimmers, and weightlifters. Organizers had positioned the games as a global competition “where elite athletes push the limits of human performance,” according to event organizers. The event was bankrolled by high-profile investors, including Peter Thiel and Donald Trump Jr.’s venture capital firm, 1789 Capitol. The atmosphere was distinctly glitzy, catering to a crowd of biotech investors and fitness influencers, yet the actual competitive output frequently fell short of the lofty predictions made since the games were first announced in 2023. For most of the five-hour broadcast, the event struggled to generate the forecasted excitement. It was not until the final event that the organization could claim a performance surpassing an official world record: Greek swimmer Kristian Gkolomeev clocked 20.81 seconds in the men’s 50m freestyle. This mark, while 0.07 seconds faster than the time set by Australian swimmer Cameron McEvoy in March, will not be recognized by governing bodies like World Athletics, which require drug testing and adherence to standard equipment regulations. Gkolomeev’s use of a specialized skinsuit—outlawed in elite international competition—further distanced the result from official records.

The Reality of Chemical Enhancement

Central to the Enhanced Games’ identity is the open embrace of substances banned in traditional sports. In the lead-up to the competition, the company announced that 91% of its athletes were using testosterone or testosterone esters, 79% were using human growth hormone, and 62% were using stimulants such as Adderall. Throughout the event, large screens displayed these statistics to the spectators, reinforcing the event’s commitment to transparency regarding doping. CEO Maximilian Martin expressed relief following the evening’s final result, framing the event as a pivotal cultural shift. “We have arrived in mainstream culture. We are here to stay. We have changed the world tonight.” Maximilian Martin, CEO of the Enhanced Games However, the medical and ethical implications of this approach remain heavily contested. Dr. Aaron Baggish, a professor of medicine at the University of Lausanne, voiced significant concerns regarding the commercialization of these substances. “I understand that there’s a very large commercial opportunity for this company, but it is something I think borders on the lines of ethics.” Dr. Aaron Baggish, University of Lausanne

The Success of Clean Athletes

A notable irony of the inaugural event was that three clean athletes—those who competed without the use of performance-enhancing drugs—secured victories. Among them was Paris silver medallist Fred Kerley, who won the men’s 100m sprint. Following his win, Kerley offered a blunt assessment of his competitors. “Man, they need to do better than that. They need to work a little bit harder, get on that shit a little bit more.” Fred Kerley, Olympic medalist and sprinter Tristan Evelyn, who also competed drug-free, won the women’s 100m final with a time of 11.25 seconds. Her victory underscored a different narrative than the one the organizers initially sought to promote. “This proves that winning takes more than chemistry.” Tristan Evelyn, 100m sprint winner Alongside American Hunter Armstrong, who won the men’s 50m backstroke, Kerley and Evelyn each took home $250,000 for their performances. These payouts were part of a total prize pool of $25 million, as confirmed by NPR. Each individual event featured a purse of $500,000, with a $250,000 prize for first place.

Commercial Aspirations and Future Viability

Beyond the spectacle of the competition, the Enhanced Group is positioning itself as a commercial entity. The company’s website functions as a telehealth platform, offering products such as testosterone injections, copper peptides, and GLP-1s. The games serve as a high-profile marketing vehicle for these products. While Martin has emphasized that the company utilizes certified doctors and medical intake forms to mitigate risks, critics argue that the business model creates inherent conflicts of interest. As The Guardian reported, the reliance on such products to fund operations and prize pools raises questions about the long-term sustainability and ethical trajectory of the venture. For now, the Enhanced Games have successfully occupied a space in the public consciousness, leveraging both the curiosity of the internet and the financial backing of high-profile tech investors. Whether this represents a lasting change in athletic competition or remains a niche, highly capitalized experiment depends on the organization’s ability to maintain momentum—and whether the market for “enhanced” athletics can sustain itself beyond the initial buzz of its first night in Las Vegas.